| 000 | 01772 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518101421.0 | ||
| 264 | 0 | _c20210412 | |
| 008 | 202104s 0 0 eng d | ||
| 022 | _a1097-0215 | ||
| 024 | 7 |
_a10.1002/ijc.33013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPiha-Paul, Sarina A | |
| 245 | 0 | 0 |
_aEfficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies. _h[electronic resource] |
| 260 |
_bInternational journal of cancer _c10 2020 |
||
| 300 |
_a2190-2198 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Immunological _xadverse effects |
| 650 | 0 | 4 |
_aB7-H1 Antigen _xmetabolism |
| 650 | 0 | 4 |
_aBiliary Tract Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aResponse Evaluation Criteria in Solid Tumors |
| 700 | 1 | _aOh, Do-Youn | |
| 700 | 1 | _aUeno, Makoto | |
| 700 | 1 | _aMalka, David | |
| 700 | 1 | _aChung, Hyun Cheol | |
| 700 | 1 | _aNagrial, Adnan | |
| 700 | 1 | _aKelley, Robin K | |
| 700 | 1 | _aRos, Willeke | |
| 700 | 1 | _aItaliano, Antoine | |
| 700 | 1 | _aNakagawa, Kazuhiko | |
| 700 | 1 | _aRugo, Hope S | |
| 700 | 1 | _ade Braud, Filippo | |
| 700 | 1 | _aVarga, Andrea Iolanda | |
| 700 | 1 | _aHansen, Aaron | |
| 700 | 1 | _aWang, Hui | |
| 700 | 1 | _aKrishnan, Suba | |
| 700 | 1 | _aNorwood, Kevin G | |
| 700 | 1 | _aDoi, Toshihiko | |
| 773 | 0 |
_tInternational journal of cancer _gvol. 147 _gno. 8 _gp. 2190-2198 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ijc.33013 _zAvailable from publisher's website |
| 999 |
_c30924685 _d30924685 |
||